|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00660 WAI CHUN BIOTEC
Nominal 
0.098 +0.006 (+6.522%) | 2023/06 - Final HKD($) | %Chg (Final to Final) | 2022/06 HKD($) | 2020/12 HKD($) | 2019/12 HKD($) | 2018/12 HKD($) | ||
| Turnover | 773,654,000 | -23.187% | 1,007,186,000 | 567,553,000 | 579,231,000 | 480,852,000 | |
| Cost of Sales | (723,241,000) | -21.130% | (917,001,000) | (518,623,000) | (530,204,000) | (465,330,000) | |
| Gross Profit | 50,413,000 | -44.100% | 90,185,000 | 48,930,000 | 49,027,000 | 15,522,000 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (2,282,000) | 537,000 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | 67,000 | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (5,698,000) | -- | 3,777,000 | 1,611,000 | 9,063,000 | (53,005,000) | |
| Taxation | (4,364,000) | -15.541% | (5,167,000) | (616,000) | (75,000) | (149,000) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (5,371,000) | -73.352% | (20,155,000) | (9,144,000) | (12,147,000) | (463,000) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (15,433,000) | -28.369% | (21,545,000) | (8,149,000) | (3,159,000) | (53,617,000) | |
| Net Finance Costs / (Income) | 17,076,000 | -18.390% | 20,924,000 | 7,889,000 | 5,816,000 | 5,890,000 | |
| Depreciation & Amortisation | 14,062,000 | -13.187% | 16,198,000 | 6,375,000 | 5,333,000 | 4,344,000 | |
| Directors' Emoluments | -- | -- | -- | 2,760,000 | 1,719,000 | 1,769,000 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) | |
Market Valuation Indicators
| EPS (cts) | -9.100 | -- | -12.900 | -4.900 | -1.900 | -32.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | 0.000 | 0.009 | -0.004 |
| NBV per share ($) | -0.204 | -- | -0.224 | -0.226 | -0.303 | -0.284 |
| Remarks: | Real time quote last updated: 04/10/2023 17:33 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -15,433,000 |
| %Change | -28.369% |
| EPS / (LPS) | HKD -0.091 |
| NBV Per Share ($) | HKD -0.204 |